Second Affiliated Hospital, Zhejiang University, School of Medicine clinical trial pipeline

18 trials changed in the last 30 days: 0 stopped, 8 with notable changes, 10 with minor changes only.

1. Notable

   Acute Normovolemic Hemodilution in Bone Cancer Surgery

   Primary completion pushed from Jul 2026 to Oct 2028

   Also in this update: Trial sites expanded: 1 → 8 locations; Study completion pushed from May 2028 to Dec 2028

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT07669155· Registry history of NCT07669155 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

2. Notable

   Camrelizumab, Chemotherapy and Ivarmacitinib · Resectable…Camrelizumab, Chemotherapy and Ivarmacitinib · Resectable Esophageal Squamous Cell Carcinoma

   Primary endpoint(s) modified

   Also in this update: Recruitment opened; Start date changed from estimate of May 1, 2026 to Aug 17, 2026

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Phase 2· NCT07505186· Registry history of NCT07505186 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

3. Notable

   Nutrition-optimized Prehabilitation on Perioperative Intervention…Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma

   Primary endpoint(s) modified

   Also in this update: Trial completed; Final enrollment: 132 participants (planned 120)

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT06549829· Registry history of NCT06549829 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

4. Notable

   taVNS · Transcutaneous Auricular Vagus Nerve Stimulation…taVNS · Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

   Enrollment reduced: 100 → 50 participants

   Also in this update: Primary completion pushed from Sep 1, 2026 to Oct 1, 2026

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT07772401· Registry history of NCT07772401 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

5. Notable

   PDT for CIN2 · Ella Photodynamic Therapy for Cervical HSIL/CIN2

   Recruitment opened

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT07306260· Registry history of NCT07306260 on ClinicalTrials.gov (opens the registry)

   Updated Oct 14, 2026

6. Notable

   Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy…Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy · Resectable Esophageal Squamous Cell Carcinoma

   Recruitment opened

   Also in this update: Start date changed from estimate of Jun 1, 2026 to Jun 3, 2026

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Phase 2· NCT07244978· Registry history of NCT07244978 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

7. Notable

   Agent-assisted, LLM-assisted and Traditional Workflows on…Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission

   Recruitment opened

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT07760051· Registry history of NCT07760051 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

8. Notable

   Single · Perclose Technique for TAVR

   Start date pushed from Oct 20, 2023 to Jan 23, 2024

   Also in this update: Trial completed; Primary completion date changed from estimate of Apr 30, 2026 to Feb 13, 2026

   Second Affiliated Hospital, Zhejiang University, School of Medicine·Not applicable· NCT06173115· Registry history of NCT06173115 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.